AscellaHealth Launches Q2 2025 Specialty & Rare Pipeline Digest™ to Support Stakeholders Navigating Specialty Drug Growth

BERWYN, Pa., July 10, 2025 (GLOBE NEWSWIRE) -- AscellaHealth, a global partner delivering customizable solutions to support the specialty pharmaceutical industry, announces the release of its Q2 2025 Specialty & Rare Pipeline Digest™. As the industry’s most comprehensive digital resource, this complimentary quarterly publication provides stakeholders with critical, up-to-date information on new, pending and upcoming specialty and rare disease drug launches and approvals, biosimilars and cell and gene therapies (CGTs). Designed to support stakeholders amid the accelerating pace of specialty drug approvals, the Digest delivers timely insights that enable proactive management and strategic utilization of emerging therapies.

To read more, click here